4 Results for "

ATWLPPR Peptide

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "ATWLPPR Peptide" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P1663A
ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis . ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1663
CAS No.: 272121-15-0
Target:  

VEGFR

Research Areas:  

Others

ATWLPPR Peptide is a biological active peptide. (This peptide is a specific VEGFR2/KDR heptapeptide antagonist, it binds VEGFR2 (KDR/flk), completely inhibiting VEGF binding to KDR and preventing VEGF-induced angiogenesis in-vivo. It specifically inhibits human endothelial cell proliferation in-vitro and totally abolishes VEGF-induced angiogenesis in-vivo.)
loading...
    loading...
Cat. No.: HY-P11286
CAS No.: 632358-46-4
Target:  

Complement System

Research Areas:  

Cancer

A7RC is a multifunctional peptide used in tumor-targeted therapy, with Cysteine added to the C-terminal of the A7R peptide (sequence: ATWLPPR). A7R (HY-P1663) is a ligand of the NRP-1 receptor, regulating intracellular signal transduction related to tumor vascularization and tumor growth .
loading...
    loading...
Cat. No.: HY-187408A
Synonyms: DOPE-PEG2000-Mal-Cys-ATWLPPR
DOPE-PEG2000-A7R (DOPE-PEG2000-Mal-Cys-ATWLPPR) is an amphiphilic lipid-PEG-peptide conjugate consisting of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the A7R peptide (sequence: ATWLPPR), a vascular endothelial growth factor receptor-2 (VEGFR-2) binding peptide. DOPE-PEG2000-A7R is used for anti-angiogenic research and tumor vasculature-targeted drug delivery.
loading...
    loading...